Inventiva (IVEVF) Accounts Payables (2018 - 2025)
Inventiva (IVEVF) posted Accounts Payables of $30.3 million for Q4 2025, down 22.9% on a QoQ basis from $39.3 million in Q2 2025, and down 13.76% year-over-year from $35.1 million in Q4 2024.
Analysis
Inventiva (IVEVF) Accounts Payables (2018 - 2025) Analysis & Trends
Inventiva has reported Accounts Payables for 8 years, with the latest figure at $30.3 million in Q4 2025.
- On a quarterly basis, Accounts Payables fell 13.76% year-over-year to $30.3 million in Q4 2025; TTM through Dec 2025 was $30.3 million, a 13.76% decrease from a year earlier, with the FY2025 full-year figure at $30.3 million, down 13.76% from the prior year.
- Accounts Payables was $30.3 million for Q4 2025 at Inventiva, down from $39.3 million in the prior quarter.
- The five-year high for Accounts Payables was $40.5 million in Q4 2023, with the low at $7538.2 in Q2 2024.
- Average Accounts Payables over 5 years is $22.8 million, with a median of $19.8 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables plunged 99.98% in 2024, then soared 521010.2% in 2025.
- Over 5 years, Accounts Payables stood at $16.7 million in 2021, then gained by 18.24% to $19.8 million in 2022, then jumped by 105.26% to $40.5 million in 2023, then retreated by 13.38% to $35.1 million in 2024, then dropped by 13.76% to $30.3 million in 2025.
- The last three Accounts Payables figures came in at $30.3 million (Q4 2025), $39.3 million (Q2 2025), and $35.1 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 4.58 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 30.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 30.28 Mn |
| Jun 30, 2025 | 39.28 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Jun 30, 2024 | 7,538.21 |
| Dec 31, 2023 | 40.54 Mn |
| Jun 30, 2023 | 31.24 Mn |
| Dec 31, 2022 | 19.75 Mn |
| Jun 30, 2022 | 15.21 Mn |
| Dec 31, 2021 | 16.70 Mn |
| Jun 30, 2021 | 12.27 Mn |
| Mar 31, 2021 | 10.48 Mn |
| Dec 31, 2020 | 8.25 Mn |
| Jun 30, 2020 | 9.39 Mn |
| Dec 31, 2019 | 8.29 Mn |
| Dec 31, 2018 | 9.56 Mn |